We are taking reports of diversion seriously. There are a number of actions we are taking. We are committed to taking those actions. They include working with safer supply providers to understand the risk mitigation measures they are taking, including patient screening and urine drug screening, and working with health care providers and patients to ensure that risk mitigation measures are in place to reduce any diversion.
We are looking at evaluations and studies, and I'm happy to turn it over to my colleague at CIHR for further information on some of the evaluations we are doing on prescribed drugs.